Simulation-Based Estimation of SARS-CoV-2 Infections Associated With School Closures and Community-Based Nonpharmaceutical Interventions in Ontario, Canada.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
entrez:
31
3
2021
pubmed:
1
4
2021
medline:
10
4
2021
Statut:
epublish
Résumé
Resurgent COVID-19 cases have resulted in the reinstitution of nonpharmaceutical interventions, including school closures, which can have adverse effects on families. Understanding the associations of school closures with the number of incident and cumulative COVID-19 cases is critical for decision-making. To estimate the association of schools being open or closed with the number of COVID-19 cases compared with community-based nonpharmaceutical interventions. This decision analytical modelling study developed an agent-based transmission model using a synthetic population of 1 000 000 individuals based on the characteristics of the population of Ontario, Canada. Members of the synthetic population were clustered into households, neighborhoods, or rural districts, cities or rural regions, day care facilities, classrooms (ie, primary, elementary, or high school), colleges or universities, and workplaces. Data were analyzed between May 5, 2020, and October 20, 2020. School reopening on September 15, 2020, vs schools remaining closed under different scenarios for nonpharmaceutical interventions. Incident and cumulative COVID-19 cases between September 1, 2020, and October 31, 2020. Among 1 000 000 simulated individuals, the percentage of infections among students and teachers acquired within schools was less than 5% across modeled scenarios. Incident COVID-19 case numbers on October 31, 2020, were 4414 (95% credible interval [CrI], 3491-5382) cases in the scenario with schools remaining closed and 4740 (95% CrI, 3863-5691) cases in the scenario for schools reopening, with no other community-based nonpharmaceutical intervention. In scenarios with community-based nonpharmaceutical interventions implemented, the incident case numbers on October 31 were 714 (95% CrI, 568-908) cases for schools remaining closed and 780 (95% CrI, 580-993) cases for schools reopening. When scenarios applied the case numbers observed in early October in Ontario, the cumulative case numbers were 777 (95% CrI, 621-993) cases for schools remaining closed and 803 (95% CrI, 617-990) cases for schools reopening. In scenarios with implementation of community-based interventions vs no community-based interventions, there was a mean difference of 39 355 cumulative COVID-19 cases by October 31, 2020, while keeping schools closed vs reopening them yielded a mean difference of 2040 cases. This decision analytical modeling study of a synthetic population of individuals in Ontario, Canada, found that most COVID-19 cases in schools were due to acquisition in the community rather than transmission within schools and that the changes in COVID-19 case numbers associated with school reopenings were relatively small compared with the changes associated with community-based nonpharmaceutical interventions.
Identifiants
pubmed: 33787909
pii: 2777976
doi: 10.1001/jamanetworkopen.2021.3793
pmc: PMC8013816
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e213793Commentaires et corrections
Type : CommentIn
Références
Lancet Infect Dis. 2020 Jun;20(6):678-688
pubmed: 32213332
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
N Engl J Med. 2020 Sep 3;383(10):981-985
pubmed: 32726550
Emerg Infect Dis. 2010 Feb;16(2):205-11
pubmed: 20113548
Influenza Other Respir Viruses. 2013 Nov;7(6):1308-15
pubmed: 23176127
Lancet Infect Dis. 2020 Jun;20(6):689-696
pubmed: 32220650
Elife. 2020 Feb 24;9:
pubmed: 32091395
Lancet Public Health. 2020 Jul;5(7):e375-e385
pubmed: 32502389
Clin Infect Dis. 2021 Mar 15;72(6):1055-1058
pubmed: 32584975
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140
pubmed: 33507890
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32597750
Lancet Infect Dis. 2021 Mar;21(3):298-299
pubmed: 33306982
Clin Infect Dis. 2020 Nov 5;71(8):1943-1946
pubmed: 32301964
Lancet Infect Dis. 2021 Mar;21(3):344-353
pubmed: 33306981
Emerg Infect Dis. 2010 Aug;16(8):1315-7
pubmed: 20678335
Lancet Child Adolesc Health. 2020 May;4(5):397-404
pubmed: 32272089
Acta Paediatr. 2020 Oct;109(10):2152-2154
pubmed: 32567145
Pediatrics. 2021 Apr;147(4):
pubmed: 33419869
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
CMAJ. 2020 May 11;192(19):E497-E505
pubmed: 32269018
Euro Surveill. 2021 Apr;26(15):
pubmed: 33860747
J Infect. 2020 Aug;81(2):e102-e103
pubmed: 32425274
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759
Disaster Med Public Health Prep. 2015 Feb;9(1):4-8
pubmed: 25739043